期刊文献+

GC-MS法测定盐酸右美托咪定中氯甲烷和氯乙烷的残留量 被引量:8

Determination of methyl chloride and ethyl chloride in dexmedetomidine hydrochloride by GC-MS
下载PDF
导出
摘要 目的建立并验证了气相色谱-质谱(GC-MS)法测定盐酸右美托咪定原料药中的基因毒性杂质氯甲烷和氯乙烷。方法色谱柱为DB-624UI毛细管柱(30 m×0.32 mm,1.8μm),程序升温,在选择离子扫描(SIM)方式下,氯甲烷m/z 50.0,氯乙烷m/z 64.0,外标法定量。结果氯甲烷和氯乙烷在100~1750 ng·m L-1与峰面积线性关系良好,两者定量限均为100 ng·m L-1,回收率均在96.5%~106.7%。结论本研究所建立的GC-MS法能用于盐酸右美托咪定原料药中氯甲烷和氯乙烷的杂质量测定。 Objective To establish a simple and sensitive GC-MS/MS method for determination of the genotoxic impurities methyl chloride and ethyl chloride in dexmedetomidine hydrochloride. Methods The analytes were separated on a DB-624UI capillary column (30 m X 0.32 mm, 1.8 μm) by programmed heating. Detection were performed by mass spectrometry in selective ion monitoring mode with m/z 50.0 for methyl chloride and m/z 64.0 for ethyl chloride. Results Good linearity was achieved in the range of 100 - 1750 ng ·mL-1 for both methyl chloride and ethyl chloride. The limit of quantification was 100 ng · mL-1. The recoveries of methyl chloride and ethyl chloride were between 96.5% and 106.7%. Conclusion It shows that the established method is useful for the determination of methyl chloride and ethyl chloride in dexmedetomidine hydrochloride.
作者 郑梅 郑枫 柳文媛 ZHENG Mei;ZHENG Feng;LIU Wen-yuan(Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009)
出处 《中南药学》 CAS 2018年第5期683-686,共4页 Central South Pharmacy
关键词 气相色谱-质谱 盐酸右美托咪定 氯甲烷 氯乙烷 基因毒性杂质 GC-MS dexmedetomidine hydrochloride methyl chloride ethyl chloride genotoxic impurity
  • 相关文献

参考文献12

二级参考文献180

  • 1顾萍,李语如.那格列奈及其片剂中L-异构体的HPLC测定[J].中国医药工业杂志,2004,35(8):486-487. 被引量:5
  • 2重症加强治疗病房病人镇痛和镇静治疗指南(2006)[J].中国实用外科杂志,2006,26(12):893-901. 被引量:215
  • 3MANTZ J. Alpharadrenoceptor agonists: analgesia, sedation, anxiolysis, haemodynamics, respiratory function and weaning [J]. Bailliere's Clin Anaesthesiol, 2000, 14(2): 443-448.
  • 4ANTTILA M, PENTTILA J, HELMINEN A, et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects [J]. Br J Clin Pharmacol, 2003, 56(6) : 691-693.
  • 5KAROL MD, MAZE M. Pharmacokinetics and interaction pharmacodynamics of dexmedetomldine in humans [J]. Bailliere's Clin Anaesthesiol, 2000, 14(2): 261-269.
  • 6KAMIBAYASHI T, MAZE M. Clinical uses of α2-adrenergic agonists[J]. Anesthesiology, 2000, 93(5) : 1345-1349.
  • 7LAKHLANI PP, MacMILLAN LB, GUO TZ, et al. Substitution of a mutant alpha2a-adrenerglc receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo[J]. Proc Natl Acad Sci USA, 1997, 94(18): 9950-9955.
  • 8MAKARITSIS KP, JOHNS C, GAVRAS I, et al. Role of alpha (2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice [J]. Hypertension, 2000, 35(2): 609-613.
  • 9SALLINEN J, HAAPALINNA A, VIITAMAA T, et al. Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mlce[J]. J Neurosci, 1998, 18(8) : 3035-3042.
  • 10AANTAA R, JAAKOLA ML, KALLIO A, et al. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine[J]. Anesthesiology, 1997, 86(5) : 1055-1060.

共引文献935

同被引文献41

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部